These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2967089)

  • 21. In vitro stability of the inhibition of serum converting enzyme by fosinopril.
    Grima M; Barthelmebs M; Stephan D; Welsch M; Imbs JL
    Fundam Clin Pharmacol; 1992; 6(2):83-8. PubMed ID: 1318861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bioavailability and disposition of [14C]omapatrilat in healthy subjects.
    Malhotra BK; Iyer RA; Soucek KM; Behr D; Liao WC; Mitroka JG; Kaul S; Cohen MB; Knupp CA
    J Clin Pharmacol; 2001 Aug; 41(8):833-41. PubMed ID: 11504270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
    Everett DW; Singhvi SM; DeForrest JM; Morrison RA; Weinstein SH; Migdalof BH
    Drug Des Deliv; 1987 Sep; 2(1):23-34. PubMed ID: 3509342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects.
    Singhvi SM; Pan HY; Morrison RA; Willard DA
    Br J Clin Pharmacol; 1990 Feb; 29(2):239-43. PubMed ID: 2106337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
    Waldemar G; Ibsen H; Strandgaard S; Andersen AR; Rasmussen S; Paulson OB
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):464-70. PubMed ID: 2142429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fosinopril (Staril)--another ACE inhibitor.
    Drug Ther Bull; 1991 Jun; 29(12):48. PubMed ID: 1834450
    [No Abstract]   [Full Text] [Related]  

  • 29. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs.
    Cushman DW; Wang FL; Fung WC; Harvey CM; DeForrest JM
    Am J Hypertens; 1989 Apr; 2(4):294-306. PubMed ID: 2706094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.
    Gavras H; Brunner HR; Turini GA; Kershaw GR; Tifft CP; Cuttelod S; Gavras I; Vukovich RA; McKinstry DN
    N Engl J Med; 1978 May; 298(18):991-5. PubMed ID: 205788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.
    Ford NF; Lasseter KC; Van Harken DR; Hammett JL; Raymond R; Manning J
    J Clin Pharmacol; 1995 Feb; 35(2):145-50. PubMed ID: 7751424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step derivatization.
    Jemal M; Ivashkiv E; Ribick M; Cohen AI
    J Chromatogr; 1985 Dec; 345(2):299-307. PubMed ID: 2935551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interaction.
    Uderman HD; Much DR; Brennan J; Delaney CL; Morgenthien EA; Weaver J; Stouffer BC; Chang SY; VanHarken D; Liao W
    Ann Pharmacother; 1999 May; 33(5):525-30. PubMed ID: 10369612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.
    Shu C; Shen H; Hopfer U; Smith DE
    Drug Metab Dispos; 2001 Oct; 29(10):1307-15. PubMed ID: 11560874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II.
    Pool JL
    Clin Ther; 1990; 12(6):520-33. PubMed ID: 2149674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics and bioavailability of cilazapril in normal man.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of benazepril relative to other ACE inhibitors.
    Gengo FM; Brady E
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.